Bharat Book Bureau

Molecular Diagnostics is the fastest growing segment in the In Vitro Diagnostics market

Press Release   •   Sep 22, 2010 16:03 IST

Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)

The report provides market landscape, competitive landscape and market trends information on ten market categories including Molecular Diagnostics, Clinical Chemistry, Hematology, Immunoassay, Point of Care Testing, Microbiology, Histology/Cytology, Flow Cytometry, Blood Screening Typing, and Coagulation. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, licensing, pipeline products and new technology offerings. The report also analyses past present and future forecast of USA, Japan, Europe, India, China and Taiwan IVD market. ( )

The report has been researched at source globally and features latest available data covering:

• Ten IVD sub-segment past, present and future forecast market share
• Six countries (USA, Japan, Europe, India, China, Taiwan) past, present, future prospects in the IVD market
• Top eight companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) IVD market share in 2009
• Top ten Merger & Acquisition deals in 2008 and 2009
• Licensing by ten IVD players
• Review of International In Vitro Diagnostics Regulations
• Key drivers of growth in the global IVD market
• Key challenges faces by IVD market in the coming years

Research Highlights

• Globally, In Vitro Diagnostics market will cross US$ 60 Billion by 2014
• Point of Care Testing dominates the In Vitro Diagnostics market with more than 30% market share in 2009
• Molecular Diagnostics is the fastest growing segment in the In Vitro Diagnostics market, its market share will reach approximately 18% by 2014
• In 2009 Roche, Siemens and Abbott Diagnostics together controls 42% market share in In Vitro Diagnostics, Roche controls the highest market share
• After Point of Care Testing, Immunoassay is the second largest market with a market of more than US$ 7 Billion in 2009
• Europe with more than US$ 10 Billion is the second largest In Vitro Diagnostics Market in 2009
• 51 Mergers & Acquisitions taken place in 2008 compared to 84 deals in 2007
• 18 In-Licensing deals were announced in 2008 compared to 27 in 2007
• By 2009 there were 12 countries with more than 10 Million people aged 60 or over
• Third Wave Technologies (TWT) was acquired by Hologic to grow its existing women’s health and diagnostics business was the best deal in 2008
• In 2009, Beckman Coulter acquired the diagnostic systems part of Olympus’s life sciences to broaden its clinical chemistry offering, especially in the ultra-high throughput setting.

For more information kindly visit :

Related Reports

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015


Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter:
Please visit our blog at

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, conferences & seminars, newsletters, and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.